The Latest Breaking News from Big Pharma

As the United States recalibrates its trade policies to combat what the Trump administration sees as “unfair” treatment by other countries, two significant industries have complained to US regulators about their treatment in Australia.

Check out these three stocks with balance sheets that have a case for being among the strongest in the entire stock market.

Most individuals diagnosed with a rare disease won’t live to become teenagers or adults. I knew what I had to do.

Small pharmacies find difficulty in prescribing the drug due to Big Pharma restrictions on the industry. ‌

A vaccine against tuberculosis has never been closer to reality. But development slowed due to corporate interests

Draft patent rules threaten pre-grant opposition, a key public health safeguard. Big pharma seeks to remove essential safeguards from India’s patent laws, creating needless hurdles in pre-grant opposition. Draft rules introduce variable fees, power to determine maintainability of representation by individuals/groups. This threatens access to quality-assured, affordable generics & extends…

Minnesota senator and anti-monopoly crusader explains how fixing Medicare's drug problem will help everybody

Health Minister Mark Holland announced in August that the federal government intends to introduce pharmacare legislation in the fall. Now the battle lines are being drawn.

J&J, Pfizer charged South Africa between 15 and 33 percent more for COVID vaccine doses, contracts reveal.

Here are just a few of the many examples of drug pricing practices that have driven consumers to demand change

The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face of the opioid epidemic: Purdue Pharma